Managers
WCP has acquired a majority stake in Realease Capital, alongside the founding CEO and deputy CEO – Régis Dodin and Cyril Marlaud respectively – as well as other key executives who are reinvesting significantly in the deal.
The transaction is to be completed by the end of September.
Realease Capital was created from the merger in 2012 between DDL (founded in 1986 by Dodin) and Comiris Capital (led by Cyril Marlaud). The Group is one of the main players in the financial leasing engineering market, active in IT, medical and industrial equipment. Realease Capital generates revenues of nearlyEUR100 million
EPIC Insurance Brokers and Consultant has acquired the assets, employees and operations of Vanbridge, a specialty insurance intermediary, program management, and risk advisory services business.
Headquartered in New York, NY, Vanbridge provides products and services at the intersection of the insurance, private equity and hedge fund industries. Vanbridge focuses on alternative asset management, corporate and individual high net worth clients; solving risk related issues utilising insurance and alternative capital.
EPIC is already the 9th largest privately owned insurance broker in the nation, before the addition of Vanbridge, which adds an additional 45 team members to the firm. EPIC has built a
Rock Rail and Aberdeen Standard Investments (ASI) have finalised an agreement to fund, purchase and then lease new fleets of trains across Europe.
Rock Rail and ASI together have already successfully financed and procured modern train fleets for three UK rail networks – a total investment of GBP2 billion. The new joint venture (JV) will draw on that expertise to focus on private financing solutions tailored for rail networks in Continental Europe and Scandinavia.
In the UK, Rock Rail and ASI have been credited with transforming the market for the procurement of trains (rolling stock). The ‘Rock ASI’ approach
Gide has advised Legrand on its purchase of Shenzhen Clever Electronic Co, a Chinese specialist in intelligent PDUs4 for data centres.
Shenzhen Clever Electronic Co rounds out Legrand’s product offerings in a high added-value segment, where it is already number one in the United States with its Raritan and Server Technology brands.
Gide advised Legrand on all aspects of the project, including legal due diligence, structuring, and negotiation and drafting of the transaction documents.
The Gide team was headed by partner David Boitout, working with Wang Zengyan and Li Jing, associates.
Ecura Helse og Omsorg (Ecura), a portfolio company of Longship Fund I, has made two new add-on acquisitions – Asor Helse and Accurate Care.
Asor Helse is a provider of home care and health services in the Norwegian market, with a focus on elderly care, personal assistance to disabled, and home health care. Accurate Care provides temporary staff for hire and qualified health personnel for permanent employment to the Norwegian health and care market. Asor Helse and Accurate Care had revenues of NOK118 million and NOK65 million, respectively in 2017.
Both companies have enjoyed solid growth in their respective
Blue Ox Healthcare Partners (Blue Ox), an investment firm focused on providing growth capital to healthcare companies in the middle market, has led a USD52 million Series E investment in Epic Sciences (Epic), a diagnostics company developing solutions to personalise and advance cancer treatment and management.
Proceeds from the fundraising round are expected to be used to accelerate Epic’s clinical studies for oncology decision support services in its pipeline and execution of its long-term growth plan.
Based in San Diego, Epic is transforming late-stage cancer treatment by applying computer vision and machine learning techniques to match patients’ individual cancer
White Oak Global Advisors has held the close of the White Oak Yield Spectrum Fund to outside investors, with approximately USD2.1 billion of total commitments, exceeding the USD1.75 billion fundraising target.
White Oak’s previous flagship fund, the White Oak Summit Fund, closed with approximately USD1.3 billion of commitments in March 2016.
The capital for the White Oak Yield Spectrum Fund was raised from a diversified group of institutional investors worldwide. In particular, the Fund attracted very strong support from public and private pension funds, insurance companies and global family offices. White Oak currently manages over USD5.6 billion of committed
Innovia Medical (Innovia), Shore Capital Partners’ specialty surgical products platform, has acquired with Eagle Laboratories (Eagle Labs), a manufacturer and distributor of ophthalmic products, focusing on single-use cannula, micro-surgical knives, and blades.
“Since their founding over 28 years ago, Eagle Labs has established themselves as a best-in-class supplier of ophthalmic cannula, knives, and blades, becoming a trusted partner and market leader in the industry. We are impressed with what the De Camp family and their team have accomplished and are excited to partner with them in the next stage of growth,” says Terry Meredith, Chief Executive Officer of Innovia.
High Road Capital Partners’ portfolio company U-C Coatings has completed the acquisition of Contechem. The deal marks High Road’s 50th transaction.
The two companies provide complementary products for protecting freshly cut lumber and logs. Based in Portland, Oregon, Contechem is a leading manufacturer of wood protection products. Contechem’s Britewood anti-stain products inhibit mould growth and discoloration on wood and lumber, and the company’s proprietary application technology and equipment reduce waste and enhance worker safety.
“Joining Contechem’s innovative sapstain products with U-C Coatings’ industry-leading wood sealants and end paints provides an ideal cross-selling opportunity and one-stop shop package to customers,”
An affiliate of HIG Capital has completed the acquisition of Reliant Rehabilitation Holdings, a provider of therapy services to skilled nursing facilities.
Headquartered in Plano, TX, Reliant is one of the largest providers of contract therapy services in the United States. The Company utilises a proprietary care model that emphasises early intervention/assessment, properly designed clinical care plans and pathways to improve patients’ functional levels. Reliant differentiates itself by possessing best-in-class therapist recruitment, program performance management, customer marketing support and industry-leading compliance systems.
Chris Bird, Chief Executive Officer of Reliant, says: “We’re excited to partner with HIG for the next
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
